How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Abstract: Sparse-view novel view synthesis (NVS) is crucial for practical applications such as AR/VR, robotics, and largescale scene reconstruction, where capturing dense multi-view images is often ...

Abstract: Spiking neural networks (SNNs) represent a biologically inspired computing paradigm capable of approximating complex temporal dynamics through sparse spiking activity. In this study, we ...

With a single click, unlock detailed, AI-assisted insights pulled from hundreds of financial data points instantly.